Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Treatment Combined With Propranolol for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis: A Randomized Controlled Trial

NCT01326949 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT01326949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01326949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Treatment Combined With Propranolol for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis: A Randomized Controlled Trial
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2011
Completion date
January 31, 2016
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding varices, decompensated cirrhosis, portal vein thrombosis